For in vitro qualitative detect of human IgG antibodies against neutralizing antibodies that block the interaction between the receptor binding domain of the viral spike glycoprotein (RBD) with the ACE2 cell surface receptor in serum, plasma and whole blood. This test is nly provided for use bv clinical laboratories or to healthcare workers for noint-of-care testing, and not for at home testingevere acute respiratory svndrome 2 is an enveloped non-segmented positive-sense RNA virus. It is the cause of disease 2019 (which is contagious in humans.It has several structural proteins including spike (S) envelope (E), membrane (M) and nucleocapsid (N). The spike protein (S) contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor, angiotensin converting enzvme-2 (ACE2). It is found that the RBD of the  Sprotein strongly interacts with the human A CE2 recentor leading to endocvtosis into the host cells of the deep lung and viral replication.Infection with the initiates an immune response. which includes the production ofl antibodies in the blood. The secreted antibodies provide protection against future infections from viruses. because thev remain in the circulatorv svstem for months to vears after infection and will bind.quickly and strongly to the pathogen to block cellular infiltration and replication. These antibodies are named neutralizing antibodies.
 

 

 

Hiealth is committed to providing point-of-care testing (POCT) products in the biomedical in vitro diagnostic (IVD) industry. We have 10 years of experience in medical testing and prevention and control.
In 2020, Hihealth began to focus on the diagnosis and treatment of CO-19. Products and services include rapid detection of colloidal gold, nucleic acid diagnosis, and Chinese medicine prevention and treatment.
Hihealth has passed various professional certifications such as CE/TUV/FDA/EUV. Overseas warehouses in Hong Kong and Europe can guarantee fast delivery.
Hiealth is committed to providing point-of-care testing (POCT) products in the biomedical in vitro diagnostic (IVD) industry. We have 10 years of experience in medical testing and prevention and control.
In 2020, Hihealth began to focus on the diagnosis and treatment of CO-19. Products and services include rapid detection of colloidal gold, nucleic acid diagnosis, and Chinese medicine prevention and treatment.
Hihealth has passed various professional certifications such as CE/TUV/FDA/EUV. Overseas warehouses in Hong Kong and Europe can guarantee fast delivery.

 

1.MOQ:
We have the MOQ limit,which is 5000 pieces.

2.Delivery date: 
After order confirmed,we will arrange your order immediately,and offer you an
estimated delivery date.

3.Payment Method:
Business to business account.

4.Shipment:
We choose Air cargo or Ocean cargo when the weight is over 300kg,and less
than 300kg,we usually select international EXPRESS(DHL).

5.Visit our factory:
Welcome visit our factory at any time

If you have more questions, please !